Aelis Farma Announces Completion of Patient Randomization for Phase 2b Study with AEF0117 for the Treatment of Cannabis Addiction
As planned, 333 patients have been randomized at end of December 2023 across 11 clinical centers in the United States This major milestone confirms the announced availability of the first…
Details